ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0519

A Multi-criterion Feature Integration Framework for Accurate Diagnosis of Primary Sjögren’s Syndrome Using Routine Laboratory Tests: A Multicentre, Retrospective Cohort study

Shu Liu1, Guanhao Wu1, Mengge Pan1, Qi Sun2, Jingchen Gao1, Xianming Long3, Chaogui Tang4, Xinran Yuan1 and Lingyun Sun1, 1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China (People's Republic), 2Department of Endocrinology and Metabolism, Affiliated Hospital of Nantong University, Nantong, China, Nantong, China (People's Republic), 3The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China (People's Republic), 4The Affiliated Huaian First People’s Hospital of Nanjing Medical University, Huai’an First People’s Hospital, Nanjing Medical University, Huaian, China (People's Republic)

Meeting: ACR Convergence 2025

Keywords: Cohort Study, Cost-Effectiveness, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0506–0521) Sjögren’s Disease – Basic & Clinical Science Poster I: Etiology, Pathogenesis, Diagnosis

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Primary Sjögren’s syndrome (pSS) is a prevalent systemic autoimmune disorder. However, the early and accurate diagnosis of pSS remains challenging due to its non-specific clinical manifestations, the absence of definitive molecular markers, and the limitations of current diagnostic tests. The present study aims to evaluate the diagnostic utility of routine laboratory tests for predicting pSS and to develop a robust, cost-effective and generalizable integrated artificial intelligence (AI) model to assist in the identification of pSS.

Methods: This multicentre, retrospective cohort study included data from 99 laboratory items of 27,432 patients with and without pSS who were admitted to one regional centre hospital and two local hospitals in China between January 1, 2013, and January 31, 2023. The construction of Sjögren Multi-criterion Feature Integration Framework (SMFIF) model was based on 16 optimal features, using multi-algorithm feature selection, SHAP value analysis, model performance evaluation, and ensemble learning strategies. The model was evaluated using an internal validation set comprising 9,329 individuals, and an external validation set consisting of 545 individuals. The primary outcome was the prediction accuracy of the model in identifying pSS.

Results: The SMFIF model attained an area under the receiver-operating characteristic curve (AUC) of 0.929 (95% CI, 0.923-0.935) in the testing set, 0.934 (95% CI, 0.929-0.939) in the internal validation set, and 0.964 (95% CI, 0.943-0.986) in the external validation set. The model demonstrated higher AUC, ACC and sensitivity in comparison with anti-SSA/Ro, anti-SSB/La, antinuclear antibodies (ANA), Globulin (GLO), Rheumatoid factor (RF), immunoglobulin G (IgG), and Complement (C3 and C4) in the diagnosis of pSS. The superior performance of SMFIF in pSS prediction was confirmed through calibration curves and confusion matrices. The SMFIF was developed as a publicly available prediction tool that will provide an estimated probability of pSS based on input laboratory data.

Conclusion: The SMFIF model has been shown to consistently achieve satisfactory performance in the prediction of pSS when utilising routine laboratory tests from the testing set and two validation sets. This model offers a low-cost, easily accessible, and accurate diagnostic tool for pSS.

Supporting image 1Study flowchart


Disclosures: S. Liu: None; G. Wu: None; M. Pan: None; Q. Sun: None; J. Gao: None; X. Long: None; C. Tang: None; X. Yuan: None; L. Sun: None.

To cite this abstract in AMA style:

Liu S, Wu G, Pan M, Sun Q, Gao J, Long X, Tang C, Yuan X, Sun L. A Multi-criterion Feature Integration Framework for Accurate Diagnosis of Primary Sjögren’s Syndrome Using Routine Laboratory Tests: A Multicentre, Retrospective Cohort study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-multi-criterion-feature-integration-framework-for-accurate-diagnosis-of-primary-sjogrens-syndrome-using-routine-laboratory-tests-a-multicentre-retrospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-multi-criterion-feature-integration-framework-for-accurate-diagnosis-of-primary-sjogrens-syndrome-using-routine-laboratory-tests-a-multicentre-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology